Success Metrics

Clinical Success Rate
92.3%

Based on 12 completed trials

Completion Rate
92%(12/13)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(5%)

Phase Distribution

Ph phase_4
6
32%
Ph phase_3
4
21%
Ph phase_2
4
21%
Ph not_applicable
3
16%

Phase Distribution

0

Early Stage

4

Mid Stage

10

Late Stage

Phase Distribution17 total trials
Phase 2Efficacy & side effects
4(23.5%)
Phase 3Large-scale testing
4(23.5%)
Phase 4Post-market surveillance
6(35.3%)
N/ANon-phased studies
3(17.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

92.3%

12 of 13 finished

Non-Completion Rate

7.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

19

all time

Status Distribution
Completed(12)
Terminated(1)
Other(6)

Detailed Status

Completed12
unknown6
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
19
Active
0
Success Rate
92.3%
Most Advanced
Phase 4

Trials by Phase

Phase 24 (23.5%)
Phase 34 (23.5%)
Phase 46 (35.3%)
N/A3 (17.6%)

Trials by Status

terminated15%
completed1263%
unknown632%

Recent Activity

0 active trials
Showing 5 of 19
completedphase_4

Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Burns

NCT04152096
completedphase_3

Cardiopulmonary Bypass Prime Solution in Patients Undergoing Heart Valve Surgery

NCT05223361
completed

Evidence Based Management of Acute Biliary Pancreatitis

NCT04615702
completedphase_4

Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Peritonitis

NCT03771170
completedphase_4

Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Sepsis.

NCT03764085
View all 19 trials

Clinical Trials (19)

Showing 19 of 19 trials
NCT04152096Phase 4

Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Burns

Completed
NCT05223361Phase 3

Cardiopulmonary Bypass Prime Solution in Patients Undergoing Heart Valve Surgery

Completed
NCT04615702

Evidence Based Management of Acute Biliary Pancreatitis

Completed
NCT03771170Phase 4

Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Peritonitis

Completed
NCT03764085Phase 4

Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Sepsis.

Completed
NCT03824457Phase 4

Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Pneumonia

Completed
NCT03118362Phase 3

Fluid Resuscitation in Burn Patients

Completed
NCT03799250Phase 4

Fluid Management in the Post Anesthesia Care Unit

Unknown
NCT04060069

Pneumoperitoneum and Trendelenburg Position on Fluid Responsiveness

Completed
NCT03697330Phase 2

Liberal Versus Restrictive Fluid Protocols in Adults

Completed
NCT02558543Phase 2

Subcutaneous Injection of Autologous Adipose Tissue-derived Stromal Vascular Fraction Into the Fingers of Patients With Systemic Sclerosis

Terminated
NCT03043131Phase 3

Comparative Analysis Between Ringer's Lactate vs Plasma Lyte-A as Cardiopulmonary Bypass Prime

Unknown
NCT02936167Not Applicable

Comparison of Ringer Lactate and Isotonic Acetate Solution as Perioperative Maintenance Fluid for Children

Unknown
NCT02866552Phase 2

SCLERoderma et Adipose-DErived Stroma Cells

Unknown
NCT02709044Phase 2

Fluid Resuscitation in Acute Pancreatitis

Unknown
NCT01242293Not Applicable

Intrapartum Hydration

Completed
NCT02634255Phase 3

The Onset Time of Rocuronium in Emergency and Elective Surgery

Unknown
NCT00797589Phase 4

Effect of Prime Solution on Fluid Balance After Open Heart Surgery

Completed
NCT01344499Not Applicable

Clearance Rate of Peritoneal Fluid After Full Conditioning Pneumoperitoneum

Completed

All 19 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
19